[EN] SUBSTITUTED DIHYDRO-BENZIMIDAZOLE COMPOUNDS AS ROR GAMMA MODULATORS<br/>[FR] UTILISATION DE COMPOSÉS SUBSTITUÉS DIHYDRO-BENZIMIDAZOLE COMME MODULATEURS DU ROR GAMMA
申请人:GLENMARK PHARMACEUTICALS SA
公开号:WO2015052675A1
公开(公告)日:2015-04-16
The present disclosure is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, as modulator of retinoid-related orphan receptor gamma t (RORyt). These compounds prevent, inhibit, or suppress the action of RORγt and are therefore useful in the treatment of RORγt mediated disease, disorder, syndrome or condition such as pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, neurodegenerative diseases or cancer.
[EN] HETEROARYL SUBSTITUTED BIPHENYL DERIVATIVES AS P38 KINASE INHIBITORS<br/>[FR] DERIVES DE BIPHENYL SUBSTITUES EN HETEROARYLE SOUS FORME D'INHIBITEURS DE P38 KINASE
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2003093248A1
公开(公告)日:2003-11-13
Compounds of formula (I) are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
The synthesis of C3-symmetrical tristriazolotriazines with conjugated arms and lateral alkoxy side chains was performed by a threefold condensation of cyanuric chloride with tetrazoles. Conjugated π segments include phenyl, tolane, and its phenylethynyl-elongated homologue. Disclike and a dendritic molecule have been obtained, and two compounds with a 3,4,5-tris(octyloxy) substitution form broad thermotropic
Tristriazolotriazines (TTTs) with a threefold alkoxyphenyl substitution were prepared and studied by DSC, polarized optical microscopy (POM) and X-ray scattering. Six pentyloxy chains are sufficient to induce liquid-crystalline behavior in these star-shaped compounds. Thermotropicproperties of TTTs with varying substitution patterns and a periphery of linear chains of different lengths, branching
[EN] ANTIVIRAL COMPOUNDS AND USE THEREOF<br/>[FR] COMPOSÉS ANTIVIRAUX ET LEUR UTILISATION
申请人:UNIV DEGLI STUDI DI SIENA
公开号:WO2019175436A1
公开(公告)日:2019-09-19
The present invention relates to compounds of formula (I), their use as medicaments, in particular as broad spectrum antiviral agents, their combination with a further antiviral agent and relative pharmaceutical compositions. In particular, the compounds of the invention are useful in the treatment of a disease caused by an enveloped virus.